Table 3.
Participants score at test (baseline) and retest for RDQ-13 scale.
| Domains | Test (n = 65) | Retest (n = 63) | Mann–Whitney U test | ||
|---|---|---|---|---|---|
| Median | IQR | Median | IQR | P-value | |
| Domain 1 | 3.00 | 3.00 to 4.00 | 4.00 | 3.00 to 4.00 | 0.024* |
| Domain 2 | 4.00 | 4.00 to 4.00 | 4.00 | 4.00 to 4.00 | 0.009* |
| Domain 3 | 4.00 | 3.00 to 4.00 | 4.00 | 3.00 to 4.00 | 0.024* |
| Domain 4 | 4.00 | 4.00 to 4.00 | 4.00 | 4.00 to 4.00 | 0.028* |
| Domain 5 | 4.00 | 4.00 to 4.00 | 4.00 | 4.00 to 4.00 | 0.756 |
| Domain 6 | 4.00 | 4.00 to 4.00 | 4.00 | 4.00 to 4.00 | 0.346 |
| Overall knowledge score | 22.00 | 20.00 to 23.00 | 23.00 | 22.00 to 23.00 | 0.003* |
| Attitude score | 11.00 | 10.00 to 12.00 | 11.00 | 10.00 to 12.00 | 0.849 |
| perception score | 9.00 | 8.00 to 10.00 | 10.00 | 9.00 to 10.00 | 0.029* |
Abbreviation: IQR = interquartile range.
*
Statistically significant at P < .05; Domains 1 to 6 are related to knowledge score. Domain 1: Related to renal dose adjustment; Domain 2: Factors to be considered when determining the appropriate dose for a patient with renal impairment; Domain 3: Medications commonly require renal dose adjustment; Domain 4: Calculating the appropriate dose for a patient with renal impairment; Domain 5: Consequences of not adjusting the dose of medications for patients with renal impairment; Domain 6: Resources to determine the appropriate dose for a patient with renal impairment.